Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable Paromomycin for Visceral Leishmaniasis in India
NCT00216346Phase 3Completed
- Sponsor
- PATH
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paromomycin in visceral leishmaniasis (VL), sponsored by PATH. Started Jun 2003; status: completed.
02
Drugs
paromomycin
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on NCT00216346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216346.